Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405269
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-05-04
Brief Title:
A Multicentre Prospective Cohort Study Effect of NeoAdjuvant Therapy on Lipids in Young Breast Cancer Patients
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Study Overview
Official Title:
A Multicentre Prospective Cohort Study Effect of NeoAdjuvant Therapy on Lipids in Young Breast Cancer Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Previous studies have shown differences in the effects of different endocrine drugs on blood lipids in breast cancer and dyslipidaemia is a major risk factor for cardiovascular disease and it has been previously reported that the leading cause of death in postmenopausal patients with breast cancer is cardiovascular disease but the effects of endocrine drug therapy on blood lipids in young breast cancer patients age 40 are not clear Previously our group conducted a preliminary retrospective analysis of young patients on endocrine therapy and found that dyslipidaemia was also a common adverse effect of treatment in young breast cancer patients therefore dyslipidaemia induced by antineoplastic therapy not only occurs in postmenopausal patients but is also prevalent in premenopausal and even younger patients Therefore this study intends to evaluate the effects of different treatment regimens on lipids in early-stage young breast cancer patients and to explore the optimal timing of lipid-lowering drug interventions to provide a basis for clinical practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None